This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Acyl carrier protein synthase inhibitor
Description: DeNovaMed’s lead program focuses on ACP synthase (AcpS), an upstream target that is present in Gram-positive, Gram-negative, and mycobacterium as well as in the Plasmodium malarial parasite.
AcpS inhibitor News
Additional information available to subscribers only: